Results 101 to 110 of about 1,158,425 (219)

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles [PDF]

open access: yes, 2011
Background: There is renewed interest in the development of poxvirus vector-based HIV vaccines due to the protective effect observed with repeated recombinant canarypox priming with gp120 boosting in the recent Thai placebo-controlled trial.
Bridge, S.   +53 more
core   +1 more source

The development of penguinpox virus (PEPV) as a vaccine vector : transfer vector construction and rescue of virus growth in rabbit kidney cells (RK-13) by vaccinia virus K1 [PDF]

open access: yes, 2010
Includes bibliographical references (leaves 131-137).Of the many vaccine trials which have taken place, the most promising results have been obtained from the recent phase 3 clinical trial which tested the ability of a dual protein and Canarypox virus ...
Hu, Nai-Chung
core   +1 more source

CENTRIFUGE EXPERIMENTS WITH THE VIRUS OF VACCINIA [PDF]

open access: yesJournal of Experimental Medicine, 1930
Centrifuge experiments have been carried out with cell-free, active filtrates of vaccinia virus. The experiments have shown that the virus can be concentrated by this method, even in filtrates which have been subjected to prolonged preliminary centrifugation to throw down any inert particles which may have been present in the original filtrate.
openaire   +2 more sources

Past and Present Vaccinations in Sweden

open access: yes
Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Sven Arne Silfverdal
wiley   +1 more source

Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope [PDF]

open access: yes, 1991
The regulatory immediate-early (IE) protein pp89 of murine cytomegalovirus induces CD8+ T lymphocytes that protect against lethal murine cytomegalovirus infection.
Ulrich   +12 more
core   +1 more source

A Recombinant Vaccinia Virus Encoding the Interferon-Inducible T-Cell Alpha Chemoattractant is Attenuated In Vivo

open access: yes, 2004
Murine interferon‐inducible T‐cell alpha chemoattractant (I‐TAC) is a potent non‐ELR CXC chemokine that predominantly attracts activated T lymphocytes, binds to the receptor CXCR3 and is induced by interferon‐γ (IFN‐γ).
Thomson, SA   +4 more
core   +1 more source

A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques

open access: yesnpj Vaccines
Shortly after 2022, mpox again becomes a public health emergency of international concern as declared by the World Health Organization on August 14, 2024.
Fengwen Xu   +23 more
doaj   +1 more source

Vaccination of Tamarin with Recombinant Vaccinia Virus Expressing Epstein Barr Virus (EBV) Latent Proteins

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2004
The aim of this work was to see whether tamarin immunisation with recombinant vaccinia virus expressing Epstein Barr Virus latent proteins could prime T cells which were, on activation, able to inhibit the outgrowth of Epstein Barr virus transformed ...
Mahmood Mahmoodian Shooshtari   +2 more
doaj  

Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara

open access: yes, 2007
Meisinger-Henschel C, Schmidt M, Lukassen S, et al. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. JOURNAL OF GENERAL VIROLOGY.
Hausmann, J.   +43 more
core   +1 more source

Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge

open access: yes, 2012
Vaccinia virus F13L encodes the envelope protein p37, which is the target of the anti-pox virus drug ST-246 (Yang et al., 2005) and that is required for production of extracellular vaccinia virus.
Vliegen, Inge   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy